Stockreport

Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in Humans

Annovis Bio, Inc.  (ANVS) 
PDF Further look at earlier Phase 1b study by ADCS unveils confirmatory data MALVERN, Pa., April 01, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS), a clinical [Read more]